Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. 1986

J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen

Acetylcholinesterase, somatostatin-like immunoreactivity, and homovanillic acid levels were measured in the cerebrospinal fluid of 36 patients with early stages of Parkinson's disease and in 19 control patients. In patients with Parkinson's disease the levels of somatostatin-like immunoreactivity were lower than in the controls (p less than 0.01); these values were lowest in the demented Parkinsonian patients. Concentrations of homovanillic acid were also significantly lower in Parkinsonian patients (p less than 0.05). In contrast, no changes were observed in the acetylcholinesterase activity of patients with Parkinson's disease. The reduced somatostatin-like immunoreactivity in CSF agrees with previous post-mortem studies and indicates that Parkinson's disease and Alzheimer's disease may have some neurochemical features in common.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D005260 Female Females
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
January 1984, Advances in neurology,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
January 1990, Journal of the American Geriatrics Society,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
December 1990, Journal of neurology, neurosurgery, and psychiatry,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
January 1982, Archiv fur Psychiatrie und Nervenkrankheiten,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
January 1986, Psychoneuroendocrinology,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
January 1988, European neurology,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
June 1997, Biological psychiatry,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
February 1986, Neuroscience research,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
January 1984, Neurobiology of aging,
J Jolkkonen, and H Soininen, and T Halonen, and A Ylinen, and V Laulumaa, and M Laakso, and P Riekkinen
September 1990, Psychiatry research,
Copied contents to your clipboard!